About Us

BIOOCUS Medical Group

BIOOCUS Medical Group is committed to advancing the research and development of cellular immunotherapies, offering innovative solutions for refractory diseases. As a leading medical group in China, we integrate the entire value chain with a cutting-edge research center, GMP-certified facilities, a CDMO platform, and comprehensive technology transfer capabilities.

With multiple CGT centers across the country, we provide specialized, high-quality treatment solutions to patients. We collaborate with top universities, research institutes, and over 20 leading hospitals worldwide to deliver transformative therapies.

Our mission is to expand access to breakthrough gene and cellular therapies, ensuring that patients receive the most advanced and effective life-saving treatments available.

About Us

Company Advantages

OUR GOAL IS TO PROVIDE THE MOST SUITABLE CELLULAR THERAPY FOR PATIENTS ALL OVER THE WORLD !

Patient Support

Our goal is to make the valuable treatment accessible to patients all over the world. Our medical tourism services are delivered to patients of China, India, Korea, Central Asia, Southeast Asia, the Middle East, South America, and Europe. We will gather global resources to support patients to get appropriate and affordable treatment.

Technology Transfering

Bioocus keeps bringing cure hope to all patients. Therefore, we closely and actively cooperate with global hospitals, provide and transfer immune cell therapy technology to the world.

Research

By collaborating with the top-level universities in China, Bioocus has leading strength in production development field. Nowadays, Bioocus has 4 product lines and will continually extending.

CDMO Platform

Bioocus is willing to support other biotech facilities to obtain standard manufacturing.

We are open to collaborate with other biotech companies whose technology could bring effective treatment results to patients.

Manufacture

Bioocus has self-owned GMP-standard facility with total floor area of 7600m².

Our Quality Control

Test report

High-tech Enterprises Certificate

Administrative Permit

Investment Record

Test Report

OUR INTRODUCTIONNIFDC AND BIOOCUS

The inspection report of cell quality testing issued by China National Institute for Food and Drug Control (CNIFDC) is the only standard for evaluating the cell quality system.

As one of the few companies in the country with a qualified report for the detection of cell value,Bioocus is an industry benchmark in terms of safety and effectiveness.

ABOUT US

Our Strategic Partners

Strategic partners are the most valuable resources to Bioocus. In 2022, Bioocus has officially signed strategic cooperation agreements with above 20 hospitals, joint clinical trials has been on the agenda. There will be more partners join Bioocus-leading projects in the future.

Contact Us for Treatment Inquiries

If you have any questions about our medical services or need detailed information about treatment options, please email us, and we will respond within 24 hours. Our dedicated medical team is here to assist you, providing professional and personalized advice tailored to your specific health needs. Feel free to reach out with any concerns or inquiries regarding your care—we’re committed to supporting you every step of the way.

click to submit an inquiry